1.Reduce TAM and induced residual TAM to polarize M2 phenotype, increase the level of tumor-infiltrating lymphocytes.2.Increased PD-1/PD-L1 expression on TAM and CTLA-4 expression on CD8+ T cells. The gene discussed is CTLA4; the disease is neoplasm.